Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference PR Newswire EMERYVILLE...
The Gross Law Firm Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a...
Final Deadline for the Kyverna Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss...
The Gross Law Firm Notifies Kyverna Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming...
Kyverna Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before February 7...
Kyverna Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Kyverna Therapeutics, Inc. Investors of...
Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery - Contact The Gross...
Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer PR...
Shareholders that lost money on Kyverna Therapeutics, Inc.(KYTX) Urged to Join Class Action - Contact The...
Kyverna Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm...
Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads